{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:53:30Z","timestamp":1793840010999,"version":"4.6.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02699-0","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:41:15Z","timestamp":1780933275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Engineering an AIEgen-based platform integrating CRISPR\/Cas9 to remodel the tumor microenvironment and reinforce photo-immunotherapy against glioblastom"],"prefix":"10.1038","volume":"11","author":[{"given":"Guanghong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingkang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Zhong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Duo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2699_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"2699_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller, M. et al. Glioma. Nat. Rev. Dis. Prim. 10, 33 (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2699_CR3","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","volume":"185","author":"FS Varn","year":"2022","unstructured":"Varn, F. S. et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell 185, 2184\u20132199 (2022).","journal-title":"Cell"},{"key":"2699_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3389\/fonc.2020.00739","volume":"10","author":"E Belykh","year":"2020","unstructured":"Belykh, E. et al. Blood-brain barrier, blood-brain tumor barrier, and fluorescence-guided neurosurgical oncology: delivering optical labels to brain tumors. Front. Oncol. 10, 739 (2020).","journal-title":"Front. Oncol."},{"key":"2699_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","volume":"623","author":"AL Ling","year":"2023","unstructured":"Ling, A. L. et al. Clinical trial links oncolytic immunoactivation to survival in glioblastoma. Nature 623, 157\u2013166 (2023).","journal-title":"Nature"},{"key":"2699_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","volume":"20","author":"CM Jackson","year":"2019","unstructured":"Jackson, C. M., Choi, J. & Lim, M. Mechanisms of immunotherapy resistance: lessons from glioblastoma. Nat. Immunol. 20, 1100\u20131109 (2019).","journal-title":"Nat. Immunol."},{"key":"2699_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","volume":"43","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Huang, D., Saw, P. E. & Song, E. Turning cold tumors hot: from molecular mechanisms to clinical applications. Trends Immunol. 43, 523\u2013545 (2022).","journal-title":"Trends Immunol."},{"key":"2699_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb2311","volume":"12","author":"T Weiss","year":"2020","unstructured":"Weiss, T. et al. Immunocytokines are a promising immunotherapeutic approach against glioblastoma. Sci. Transl. Med. 12, eabb2311 (2020).","journal-title":"Sci. Transl. Med."},{"key":"2699_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197\u2013218 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2699_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44941-9","volume":"15","author":"M Zhao","year":"2024","unstructured":"Zhao, M. et al. Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy. Nat. Commun. 15, 950 (2024).","journal-title":"Nat. Commun."},{"key":"2699_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41568-022-00441-w","volume":"22","author":"A Katti","year":"2022","unstructured":"Katti, A., Diaz, B. J., Caragine, C. M., Sanjana, N. E. & Dow, L. E. CRISPR in cancer biology and therapy. Nat. Rev. Cancer 22, 259\u2013279 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"2699_CR12","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/s41587-023-02118-7","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. An oncolytic virus-T cell chimera for cancer immunotherapy. Nat. Biotechnol. 42, 1876\u20131887 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2699_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli, L., Pacher, P., Vizi, E. S. & Hasko, G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19, 355\u2013367 (2013).","journal-title":"Trends Mol. Med."},{"key":"2699_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04359-3","volume":"12","author":"M Wang","year":"2021","unstructured":"Wang, M., Jia, J., Cui, Y., Peng, Y. & Jiang, Y. CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal expansion. Cell Death Dis. 12, 1065 (2021).","journal-title":"Cell Death Dis."},{"key":"2699_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trecan.2016.01.003","volume":"2","author":"L Antonioli","year":"2016","unstructured":"Antonioli, L., Yegutkin, G. G., Pacher, P., Blandizzi, C. & Hask\u00f3, G. Anti-CD73 in cancer immunotherapy: awakening new opportunities. Trends Cancer 2, 95\u2013109 (2016).","journal-title":"Trends Cancer"},{"key":"2699_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-019-0694-x","volume":"26","author":"S Goswami","year":"2020","unstructured":"Goswami, S. et al. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma. Nat. Med. 26, 39\u201346 (2020).","journal-title":"Nat. Med."},{"key":"2699_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46343-3","volume":"15","author":"KB Lupo","year":"2024","unstructured":"Lupo, K. B. et al. synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Nat. Commun. 15, 1909 (2024).","journal-title":"Nat. Commun."},{"key":"2699_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302498","volume":"10","author":"Q Chen","year":"2023","unstructured":"Chen, Q. et al. Tumor microenvironment responsive CD8(+) T cells and myeloid-derived suppressor cells to trigger CD73 inhibitor AB680-based synergistic therapy for pancreatic cancer. Adv. Sci. 10, e2302498 (2023).","journal-title":"Adv. Sci."},{"key":"2699_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107507118","volume":"118","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells. Proc. Natl. Acad. Sci. USA 118, e2107507118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2699_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1158\/2159-8290.CD-14-0341","volume":"4","author":"A Young","year":"2014","unstructured":"Young, A., Mittal, D., Stagg, J. & Smyth, M. J. Targeting cancer-derived adenosine: new therapeutic approaches. Cancer Discov. 4, 879\u2013888 (2014).","journal-title":"Cancer Discov."},{"key":"2699_CR21","first-page":"5626","volume":"19","author":"B Allard","year":"2013","unstructured":"Allard, B., Pommey, S., Smyth, M. J. & Stagg, J. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs. J. Am. Assoc. Cancer Res. 19, 5626\u20135635 (2013).","journal-title":"J. Am. Assoc. Cancer Res."},{"key":"2699_CR22","doi-asserted-by":"publisher","first-page":"9447","DOI":"10.1021\/acs.jmedchem.4c00553","volume":"67","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Discovery of small and bifunctional molecules targeting PD-L1\/CD73 for cancer dual immunotherapy. J. Med. Chem. 67, 9447\u20139464 (2024).","journal-title":"J. Med. Chem."},{"key":"2699_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202405673","volume":"36","author":"XC Deng","year":"2024","unstructured":"Deng, X. C. et al. Interference of ATP-adenosine axis by engineered biohybrid for amplifying immunogenic cell death-mediated antitumor immunotherapy. Adv. Mater. 36, e2405673 (2024).","journal-title":"Adv. Mater."},{"key":"2699_CR24","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1021\/acsnano.2c11403","volume":"17","author":"Q Chen","year":"2023","unstructured":"Chen, Q. et al. Combining high-Z sensitized radiotherapy with CD73 blockade to boost tumor immunotherapy. ACS Nano 17, 12087\u201312100 (2023).","journal-title":"ACS Nano"},{"key":"2699_CR25","doi-asserted-by":"publisher","first-page":"23001","DOI":"10.1021\/acsnano.4c04553","volume":"18","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Boost infiltration and activity of T cells via inhibiting Ecto-5\u2019-nucleotidase (CD73) immune checkpoint to enhance glioblastoma immunotherapy. ACS Nano 18, 23001\u201323013 (2024).","journal-title":"ACS Nano"},{"key":"2699_CR26","doi-asserted-by":"publisher","first-page":"18491","DOI":"10.1021\/acs.jmedchem.4c01793","volume":"67","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. Discovery of novel 5-(Pyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione derivatives as potent and orally bioavailable inhibitors targeting Ecto-5\u2032-nucleotidase. J. Med. Chem. 67, 18491\u201318511 (2024).","journal-title":"J. Med. Chem."},{"key":"2699_CR27","doi-asserted-by":"publisher","first-page":"11039","DOI":"10.1021\/acs.jmedchem.5c00035","volume":"68","author":"L Cen","year":"2025","unstructured":"Cen, L. et al. Discovery of Orally Potent Small-Molecule CD73 Inhibitor for Cancer Immunotherapy. J. Med Chem. 68, 11039\u201311061 (2025).","journal-title":"J. Med Chem."},{"key":"2699_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20220115","volume":"3","author":"H Peng","year":"2023","unstructured":"Peng, H. et al. Unraveling mitochondria-targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials. Exploration 3, 20220115 (2023).","journal-title":"Exploration"},{"key":"2699_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41578-024-00684-z","volume":"9","author":"F Hameedat","year":"2024","unstructured":"Hameedat, F. et al. Engineering nanomaterials for glioblastoma nanovaccination. Nat. Rev. Mater. 9, 628\u2013642 (2024).","journal-title":"Nat. Rev. Mater."},{"key":"2699_CR30","first-page":"26","volume":"9","author":"QL Guo","year":"2022","unstructured":"Guo, Q. L. et al. Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives. Mil. Med. Res. 9, 26 (2022).","journal-title":"Mil. Med. Res."},{"key":"2699_CR31","doi-asserted-by":"publisher","first-page":"20210106","DOI":"10.1002\/EXP.20210106","volume":"2","author":"Y Ding","year":"2022","unstructured":"Ding, Y., Wang, Y. & Hu, Q. Recent advances in overcoming barriers to cell-based delivery systems for cancer immunotherapy. Exploration 2, 20210106 (2022).","journal-title":"Exploration"},{"key":"2699_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202304419","volume":"62","author":"S Chi","year":"2023","unstructured":"Chi, S. et al. Biomimetic nanocomposites camouflaged with hybrid cell membranes for accurate therapy of early-stage glioma. Angew. Chem. Int. Ed. Engl. 62, e202304419 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2699_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122694","volume":"311","author":"H You","year":"2024","unstructured":"You, H. et al. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma. Biomaterials 311, 122694 (2024).","journal-title":"Biomaterials"},{"key":"2699_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20220014","volume":"2","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Gd(2)O(3)\/b-TiO(2) composite nanoprobes with ultra-high photoconversion efficiency for MR image-guided NIR-II photothermal therapy. Exploration 2, 20220014 (2022).","journal-title":"Exploration"},{"key":"2699_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.396","volume":"5","author":"X He","year":"2024","unstructured":"He, X. et al. D-type neuropeptide decorated AIEgen\/RENP hybrid nanoprobes with light-driven ROS generation ability for NIR-II fluorescence imaging-guided through-skull photodynamic therapy of gliomas. Aggregate 5, e396 (2024).","journal-title":"Aggregate"},{"key":"2699_CR36","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41565-022-01189-y","volume":"17","author":"H Arami","year":"2022","unstructured":"Arami, H. et al. Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars. Nat. Nanotechnol. 17, 1015\u20131022 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"2699_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2023.215070","volume":"482","author":"Y Duo","year":"2023","unstructured":"Duo, Y. et al. Aggregation-induced emission: an illuminator in the brain. Coord. Chem. Rev. 482, 215070 (2023).","journal-title":"Coord. Chem. Rev."},{"key":"2699_CR38","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1039\/D2CS00610C","volume":"52","author":"Y Duo","year":"2023","unstructured":"Duo, Y. et al. Noncancerous disease-targeting AIEgens. Chem. Soc. Rev. 52, 1024\u20131067 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"2699_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.680","volume":"6","author":"Y Song","year":"2024","unstructured":"Song, Y., Tong, X., Han, Y. & Zhang, Q.-W. Finely tunable NIR-II organic scaffolds for fluorescence\/photoacoustic duplex imaging\u2013guided noninvasive photothermal therapy of glioblastoma. Aggregate 6, e680 (2024).","journal-title":"Aggregate"},{"key":"2699_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202106082","volume":"34","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Brain-targeted aggregation-induced-emission nanoparticles with near-infrared imaging at 1550 nm boosts orthotopic glioblastoma theranostics. Adv. Mater. 34, e2106082 (2022).","journal-title":"Adv. Mater."},{"key":"2699_CR41","doi-asserted-by":"publisher","first-page":"2310237","DOI":"10.1002\/adfm.202310237","volume":"34","author":"X Lin","year":"2024","unstructured":"Lin, X. et al. Engineered microglia-exosomes coated highly twisting aie photothermal agents to efficiently cross blood-brain-barrier for mild photothermal-immune checkpoint blockade therapy in glioblastoma. Adv. Funct. Mater. 34, 2310237 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"2699_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121981","volume":"293","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Genetically edited T-cell membrane coated AIEgen nanoparticles effectively prevents glioblastoma recurrence. Biomaterials 293, 121981 (2023).","journal-title":"Biomaterials"},{"key":"2699_CR43","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1021\/acsnano.0c03824","volume":"14","author":"G Deng","year":"2020","unstructured":"Deng, G. et al. Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-ii fluorescence-guided glioma theranostics. ACS Nano 14, 11452\u201311462 (2020).","journal-title":"ACS Nano"},{"key":"2699_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300665","volume":"36","author":"K Yi","year":"2024","unstructured":"Yi, K. et al. Engineered nanomaterials to potentiate CRISPR\/Cas9 gene editing for cancer therapy. Adv. Mater. 36, e2300665 (2024).","journal-title":"Adv. Mater."},{"key":"2699_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202307078","volume":"20","author":"F Tang","year":"2024","unstructured":"Tang, F. et al. Gene and photothermal combination therapy: principle, materials, and amplified anticancer intervention. Small 20, e2307078 (2024).","journal-title":"Small"},{"key":"2699_CR46","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1039\/D2SC00459C","volume":"13","author":"D Luo","year":"2022","unstructured":"Luo, D. et al. A dynamic DNA nanosponge for triggered amplification of gene-photodynamic modulation. Chem. Sci. 13, 5155\u20135163 (2022).","journal-title":"Chem. Sci."},{"key":"2699_CR47","doi-asserted-by":"crossref","unstructured":"Wang, F. et al. A Spatiotemporally controlled gene-regulation strategy for combined tumor therapy based on upconversion hybrid nanosystem. Adv. Sci. e2405640 (2024).","DOI":"10.1002\/advs.202405640"},{"key":"2699_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201807376","volume":"29","author":"Y Tang","year":"2019","unstructured":"Tang, Y. et al. Bio-erasable intermolecular donor\u2013acceptor interaction of organic semiconducting nanoprobes for activatable NIR-II fluorescence imaging. Adv. Funct. Mater. 29, 1807376 (2019).","journal-title":"Adv. Funct. Mater."},{"key":"2699_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202008802","volume":"33","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Upregulating aggregation-induced-emission nanoparticles with blood-tumor-barrier permeability for precise photothermal eradication of brain tumors and induction of local immune responses. Adv. Mater. 33, e2008802 (2021).","journal-title":"Adv. Mater."},{"key":"2699_CR50","doi-asserted-by":"publisher","first-page":"20151","DOI":"10.1021\/acsnano.2c04465","volume":"16","author":"R Xu","year":"2022","unstructured":"Xu, R. et al. All-in-one theranostic platforms: deep-red AIE nanocrystals to target dual-organelles for efficient photodynamic therapy. ACS Nano 16, 20151\u201320162 (2022).","journal-title":"ACS Nano"},{"key":"2699_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08722-z","volume":"10","author":"Z Zhao","year":"2019","unstructured":"Zhao, Z. et al. Highly efficient photothermal nanoagent achieved by harvesting energy via excited-state intramolecular motion within nanoparticles. Nat. Commun. 10, 768 (2019).","journal-title":"Nat. Commun."},{"key":"2699_CR52","doi-asserted-by":"publisher","first-page":"9431","DOI":"10.1021\/acsnano.3c11078","volume":"18","author":"F Ma","year":"2024","unstructured":"Ma, F. et al. Boosting luminescence efficiency of near-infrared-II aggregation-induced emission luminogens via a mash-up strategy of pi-extension and deuteration for dual-model image-guided surgery. ACS Nano 18, 9431\u20139442 (2024).","journal-title":"ACS Nano"},{"key":"2699_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/adom.202100859","volume":"9","author":"Z Xu","year":"2021","unstructured":"Xu, Z. et al. Aggregation-induced emission nanoprobes working in the NIR-II region: from material design to fluorescence imaging and phototherapy. Adv. Opt. Mater. 9, 2100859 (2021).","journal-title":"Adv. Opt. Mater."},{"key":"2699_CR54","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s44222-024-00196-z","volume":"2","author":"G Obaid","year":"2024","unstructured":"Obaid, G. et al. Engineering photodynamics for treatment, priming and imaging. Nat. Rev. Bioeng. 2, 752\u2013769 (2024).","journal-title":"Nat. Rev. Bioeng."},{"key":"2699_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30306-7","volume":"13","author":"X Li","year":"2022","unstructured":"Li, X. et al. Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nat. Commun. 13, 2794 (2022).","journal-title":"Nat. Commun."},{"key":"2699_CR56","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.apsb.2022.08.012","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Reprogrammed siTNF\u03b1\/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy. Acta Pharm. Sin. B 13, 787\u2013803 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"2699_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159\u2013175 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2699_CR58","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nnano.2017.54","volume":"12","author":"J Xue","year":"2017","unstructured":"Xue, J. et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol. 12, 692\u2013700 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"2699_CR59","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.cell.2020.11.019","volume":"183","author":"M Buggert","year":"2020","unstructured":"Buggert, M. et al. The identity of human tissue-emigrant CD8(+) T cells. Cell 183, 1946\u20131961 (2020).","journal-title":"Cell"},{"key":"2699_CR60","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.apsb.2023.12.004","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies. Acta Pharm. Sin. B 14, 1951\u20131964 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"2699_CR61","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ccell.2024.01.002","volume":"42","author":"DD Klysz","year":"2024","unstructured":"Klysz, D. D. et al. Inosine induces stemness features in CAR-T cells and enhances potency. Cancer Cell 42, 266\u2013282 (2024).","journal-title":"Cancer Cell"},{"key":"2699_CR62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","volume":"11","author":"CA-O Jacoberger-Foissac","year":"2023","unstructured":"Jacoberger-Foissac, C. A.-O. et al. CD73 Inhibits cGAS-STING and cooperates with CD39 to promote pancreatic cancer. Cancer Immunol. Res 11, 56\u201371 (2023).","journal-title":"Cancer Immunol. Res"},{"key":"2699_CR63","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ccell.2023.01.002","volume":"41","author":"IL Linde","year":"2023","unstructured":"Linde, I. L. et al. Neutrophil-activating therapy for the treatment of cancer. Cancer Cell 41, 356\u2013372 (2023).","journal-title":"Cancer Cell"},{"key":"2699_CR64","doi-asserted-by":"publisher","first-page":"C1079","DOI":"10.1152\/ajpcell.00285.2019","volume":"317","author":"M Minor","year":"2019","unstructured":"Minor, M., Alcedo, K. P., Battaglia, R. A. & Snider, N. Cell type- and tissue-specific functions of ecto-5\u2019-nucleotidase (CD73). Am. J. Physiol. Cell Physiol. 317, C1079\u2013C1092 (2019).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2699_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv5673","volume":"11","author":"G Yang","year":"2025","unstructured":"Yang, G. et al. Glioblastoma exploits ATP from leading-edge astrocytes to fuel its infiltrative growth revealed by spatially resolved chimeric analysis. Sci. Adv. 11, eadv5673 (2025).","journal-title":"Sci. Adv."},{"key":"2699_CR66","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.cell.2025.12.055","volume":"189","author":"M Meylan","year":"2026","unstructured":"Meylan, M. et al. Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial. Cell 189, 1287\u20131304 (2026).","journal-title":"Cell"},{"key":"2699_CR67","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ccell.2025.11.006","volume":"44","author":"H Piyadasa","year":"2026","unstructured":"Piyadasa, H. et al. Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence. Cancer Cell 44, 112\u2013128 (2026).","journal-title":"Cancer Cell"},{"key":"2699_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202516348","volume":"65","author":"D Qu","year":"2026","unstructured":"Qu, D. et al. Biodegradable nano-regulator reprograms glioblastoma immunosuppression: pyroptosis-metabolism-immunity crosstalk for cascading immune activation. Angew. Chem. Int. Ed. Engl. 65, e16348 (2026).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2699_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121503","volume":"284","author":"M Yu","year":"2022","unstructured":"Yu, M. et al. ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy. Biomaterials 284, 121503 (2022).","journal-title":"Biomaterials"},{"key":"2699_CR70","doi-asserted-by":"crossref","unstructured":"Taha, B. A. et al. Perspective of smart nanocapsule swallowable laser-guided for integrated sensing and crispr-mediated cancer gene editing. Cancer Gene Ther. 1\u201315 (2026).","DOI":"10.1038\/s41417-026-01004-z"},{"key":"2699_CR71","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41590-025-02153-3","volume":"26","author":"TJ Sanders","year":"2025","unstructured":"Sanders, T. J. et al. Inhibition of ENT1 relieves intracellular adenosine-mediated T\u2009cell suppression in cancer. Nat. Immunol. 26, 854\u2013865 (2025).","journal-title":"Nat. Immunol."},{"key":"2699_CR72","doi-asserted-by":"crossref","unstructured":"Guo, B. et al. Through scalp and skull NIR-II photothermal therapy of deep orthotopic brain tumors with precise photoacoustic imaging guidance. Adv. Mater. 30, 1802591 (2018).","DOI":"10.1002\/adma.201802591"},{"key":"2699_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63081-2","volume":"16","author":"R Zhao","year":"2025","unstructured":"Zhao, R. et al. Bioengineered hybrid dual-targeting nanoparticles reprogram the tumour microenvironment for deep glioblastoma photodynamic therapy. Nat. Commun. 16, 7672 (2025).","journal-title":"Nat. Commun."},{"key":"2699_CR74","doi-asserted-by":"crossref","unstructured":"Yu, Y. et al. Self-adaptive photodynamic-to-photothermal switch for smart antitumor photoimmunotherapy. ACS Nano 18, 13019\u201313034 (2024).","DOI":"10.1021\/acsnano.4c01600"},{"key":"2699_CR75","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41565-023-01374-7","volume":"18","author":"Z Luo","year":"2023","unstructured":"Luo, Z. et al. Neutrophil hitchhiking for drug delivery to the bone marrow. Nat. Nanotechnol. 18, 647\u2013656 (2023).","journal-title":"Nat. Nanotechnol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02699-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02699-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02699-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:02:57Z","timestamp":1780938177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02699-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2699"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02699-0","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}